| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/2009 | US20090118362 Chemotherapeutic agents for inhibition of protein translation |
| 05/07/2009 | US20090118361 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 05/07/2009 | US20090118360 Process for manufacturing leaf tea |
| 05/07/2009 | US20090118359 Food product |
| 05/07/2009 | US20090118358 Kainate Receptor-Selective Epimeric Analogs of Dysiherbaine |
| 05/07/2009 | US20090118357 Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| 05/07/2009 | US20090118356 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 05/07/2009 | US20090118355 Fluorotaxoids |
| 05/07/2009 | US20090118354 Liquid Pharmaceutical Formulations of Docetaxel |
| 05/07/2009 | US20090118353 Medicinal composition |
| 05/07/2009 | US20090118352 Broad spectrum microbicidal and spermicidal compositions and methods |
| 05/07/2009 | US20090118351 Angiotensin I-Converting Enzyme (ACE) Inhibitors |
| 05/07/2009 | US20090118350 Biomarkers for Identifying Efficacy of Tegaserod in Patients with Chronic Constipation |
| 05/07/2009 | US20090118349 Bis-alkylating agents and their use in cancer therapy |
| 05/07/2009 | US20090118348 Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| 05/07/2009 | US20090118347 Method of Treating Down Syndrome |
| 05/07/2009 | US20090118345 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/07/2009 | US20090118344 Crystalline Chemotherapeutic |
| 05/07/2009 | US20090118343 Treatment of severe distal colitis |
| 05/07/2009 | US20090118342 Design and synthesis of biotinylated probes for n-acyl-ethanolamines |
| 05/07/2009 | US20090118341 Method for treatment of chronic neuropathic pain |
| 05/07/2009 | US20090118340 Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers |
| 05/07/2009 | US20090118339 Lysine related derivatives as hiv aspartyl protease inhibitors |
| 05/07/2009 | US20090118338 Aryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/07/2009 | US20090118337 Methods and compositions for treating inflammation |
| 05/07/2009 | US20090118336 Pyrazole derivatives and their use as pi3k inhibitors |
| 05/07/2009 | US20090118335 Acid Secretion Inhibitor |
| 05/07/2009 | US20090118334 Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blocker |
| 05/07/2009 | US20090118333 Amides useful as inhibitors of voltage-gated sodium channels |
| 05/07/2009 | US20090118332 Therapeutic Agents - 551 |
| 05/07/2009 | US20090118331 Use of Lobeline Epimers in the Treatment of Central Nervous System Diseases, Pathologies, and Drug Abuse |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118329 Novel Substituted 2-Amino-4-Phenyldihydroquinolines, Processes for their Preparation, Pharmaceutical Compositions and Methods for Their Use |
| 05/07/2009 | US20090118328 Pharmaceutical Compositions Of Cholesteryl Ester Transfer Protein Inhibitors And Hmg-Coa Reductase |
| 05/07/2009 | US20090118327 Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them |
| 05/07/2009 | US20090118326 Nicotinic Acetylcholine Receptor Modulators |
| 05/07/2009 | US20090118325 5-Thioxylopyranose Compounds |
| 05/07/2009 | US20090118324 Mapk/erk kinase inhibitors |
| 05/07/2009 | US20090118323 Antitumor benzoylsulfonamides |
| 05/07/2009 | US20090118322 Agent for repairing corneal sensitivity containing amide compound |
| 05/07/2009 | US20090118321 5-Urea Substituted Naphthalimide Derivatives, Methods of Production and Pharmaceutical Compositions for Treating Cancer |
| 05/07/2009 | US20090118320 Derivatives of 5,9-methanocycloocta[b]pyridin-2-(1h)-one, their preparation and use as analgesics |
| 05/07/2009 | US20090118319 Fused and Spirocycle Compounds and the Use Thereof |
| 05/07/2009 | US20090118318 Novel Diazaspiroalkanes and Their Use for Treatment of CCR8 Mediated Diseases |
| 05/07/2009 | US20090118317 Statin-Carboxyalkylether Combinations |
| 05/07/2009 | US20090118316 Methods for Augmenting Bone |
| 05/07/2009 | US20090118315 Methods of Treatment Using Sapacitabine |
| 05/07/2009 | US20090118314 Tumor suppressor |
| 05/07/2009 | US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase |
| 05/07/2009 | US20090118312 flavivirus antivirals based on1,6-diazacyclotetradecane with fused pyrrolidine or cyclopentane ring at positions 3,4 and methylene bridge at positions 7,8; macrocyclic ring substituted with quinazolin-4-yloxy substituent on the fused pyrrolidine or cyclopentane ring |
| 05/07/2009 | US20090118311 DHFR Enzyme Inhibitors |
| 05/07/2009 | US20090118310 Activated Cdc42-associated kinase (ACK) as a therapeutic target for Ras-induced cancer |
| 05/07/2009 | US20090118309 Selective antagonists of A2A adenosine receptors |
| 05/07/2009 | US20090118308 2,2-Bis-(hydroxymethyl)cyclopropylidenemethyl-Purines and -Pyrimidines As Antiviral Agents |
| 05/07/2009 | US20090118307 Aryl Sulfonamides |
| 05/07/2009 | US20090118306 Novel use of liver X receptor agonists |
| 05/07/2009 | US20090118305 Pyridine and pyrazine derivatives - 083 |
| 05/07/2009 | US20090118304 2-heteroaryl-substituted indole derivative |
| 05/07/2009 | US20090118303 Serotonin 5-ht3 receptor agonist |
| 05/07/2009 | US20090118302 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses |
| 05/07/2009 | US20090118301 Compositions and Methods for Treating Cancer |
| 05/07/2009 | US20090118300 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators |
| 05/07/2009 | US20090118299 Agent for prevention or treatment of glaucoma |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118297 Polymorphs of dasatinib and process for preparation thereof |
| 05/07/2009 | US20090118296 Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase |
| 05/07/2009 | US20090118294 Compositions and methods related to heart failure |
| 05/07/2009 | US20090118293 Methods for reducing hospitalizations related to heart failure |
| 05/07/2009 | US20090118292 Cytokine inhibitors |
| 05/07/2009 | US20090118291 Histone deacetylase inhibitors |
| 05/07/2009 | US20090118290 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| 05/07/2009 | US20090118289 (Biphenyl) Carboxylic Acids and Derivatives Thereof |
| 05/07/2009 | US20090118288 N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Receptor |
| 05/07/2009 | US20090118287 Organic compounds |
| 05/07/2009 | US20090118285 Use of kcnq-openers for treating or reducing the symptoms of schizophrenia |
| 05/07/2009 | US20090118284 Novel compounds that are ERK inhibitors |
| 05/07/2009 | US20090118283 Amide Derivatives as Kinase Inhibitors |
| 05/07/2009 | US20090118282 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 05/07/2009 | US20090118281 Amino Alcohol Derivatives And Their Use As Renin Inhibitor |
| 05/07/2009 | US20090118280 schizophrenia; 1-[4-(4-morpholinylcarbonyl)phenyl]-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole; administered alone or with another antipsychotic drug |
| 05/07/2009 | US20090118279 Compound containing basic group and use thereof |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118277 3 Unsubstituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors |
| 05/07/2009 | US20090118276 Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors |
| 05/07/2009 | US20090118275 Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| 05/07/2009 | US20090118274 Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 05/07/2009 | US20090118273 Compounds and Compositions as Protein Kinase Inhibitors |
| 05/07/2009 | US20090118272 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 05/07/2009 | US20090118271 Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug |
| 05/07/2009 | US20090118270 Phosphodiesterase 4 inhibitors |
| 05/07/2009 | US20090118269 Methods for Treating Spinal Muscular Atrophy Using Tetracycline Compounds |
| 05/07/2009 | US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 05/07/2009 | US20090118267 Indanes |
| 05/07/2009 | US20090118266 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 05/07/2009 | US20090118265 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 05/07/2009 | US20090118264 Medicament having neovascularization promoting action |
| 05/07/2009 | US20090118263 Novel Adenine Compound |
| 05/07/2009 | US20090118262 Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery |
| 05/07/2009 | US20090118261 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/07/2009 | US20090118260 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |